Suppr超能文献

微流控技术合成活体组织。

Synthesizing Living Tissues with Microfluidics.

机构信息

Beijing Engineering Research Center for BioNanotechnology and CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience , National Center for NanoScience and Technology , Beijing 100190 , P. R. China.

Department of Biomedical Engineering , Southern University of Science and Technology, No. 1088 Xueyuan Rd, Nanshan District, Shenzhen , Guangdong 518055 , P. R. China.

出版信息

Acc Chem Res. 2018 Dec 18;51(12):3166-3173. doi: 10.1021/acs.accounts.8b00417. Epub 2018 Nov 20.

Abstract

In native tissues, various cell types organize and spatiotemporally function and communicate with neighboring or remote cells in a highly regulated way. How can we replicate these amazing functional structures in vitro? From the view of a chemist, the heterogeneous cells and extracellular matrix (ECM) could be regarded as various chemical substrate materials for "synthetic" reactions during tissue engineering. But how can we accelerate these reactions? Microfluidics provides ideal solutions. Microfluidics could be metaphorically regarded as a miniature "biofactory", whereas the on-chip critical chemical cues such as biomolecule gradients and physical cues such as geometrical confinement, topological guidance, and mechanical stimulations, along with the external stimulations such as light, electricity, acoustics, and magnetics, could be regarded as "catalytic cues" which can accelerate the "synthetic reactions" by precisely and effectively manipulating a series of cell behaviors including cell adhesion, migration, growth, proliferation, differentiation, cell-cell interaction, and cell-matrix interaction to reduce activation energy of the "synthetic reactions". Thus, on the microfluidics platform, the "biofactory", various "synthetic" reactions take place to change the substrate materials (cells and ECM) into products (tissues) in a nonlinear way, which is a typical feature of a biological process. By precisely organizing the substrate materials and spatiotemporally controlling the activity of the products, as a "biofactory", the microfluidics system can not only "synthesize" living tissues but also recreate physiological or pathophysiological processes such as immune responses, angiogenesis, wound healing, and tumor metastasis in vitro to bring insights into the mechanisms underlying these processes taking place in vivo. In this Account, we borrow the concept of chemical "synthesis" to describe how to "synthesize" artificial tissues using microfluidics from a chemist's view. Accelerated by the built-in physiochemical cues on microfluidics and external stimulations, various tissues could be "synthesized" on a microfluidics platform. We summarize that there are "step-by-step synthesis" and "one-step synthesis" on microfluidics for creating desired tissues with unprecedented precision, accuracy, and speed. In recent years, researchers developed various microfluidic techniques including creating adhesive domains for mediating reverse and precise adhesion, chemical gradients for directing cell growth, geometrical confinements and topological cues for manipulating cell migration, and mechanics for stimulating cell differentiation. By employing and orchestrating these on-chip tissue "synthetic" conditions, "step-by-step synthesis" could be realized on chips to develop multilayered tissues such as blood vessels. "One-step synthesis" on chips could develop functional three-dimensional tissue structures such as neural networks or nephron-like structures. Based on these on-chip studies, many critical physiological and pathophysiological processes such as wound healing, tumor metastasis, and atherosclerosis could be deeply investigated, and the drugs or therapeutic approaches could also be evaluated or screened conveniently. The "synthetic tissues on microfluidics" system would pave an avenue for precise creation of artificial tissues for not only fundamental research but also biomedical applications such as tissue engineering.

摘要

在天然组织中,各种细胞类型以高度调节的方式组织并在时空上与邻近或远程细胞相互作用和通讯。我们如何在体外复制这些惊人的功能结构?从化学家的角度来看,异质细胞和细胞外基质 (ECM) 可以被视为组织工程中“合成”反应的各种化学底物材料。但是我们如何加速这些反应呢?微流控提供了理想的解决方案。微流控可以被比喻为一个微型“生物工厂”,而芯片上的关键化学线索,如生物分子梯度和物理线索,如几何限制、拓扑引导和机械刺激,以及外部刺激,如光、电、声和磁,可以被视为“催化线索”,通过精确有效地操纵一系列细胞行为,包括细胞黏附、迁移、生长、增殖、分化、细胞-细胞相互作用和细胞-基质相互作用,来加速“合成反应”,从而降低“合成反应”的活化能。因此,在微流控平台这个“生物工厂”上,各种“合成”反应以非线性的方式将底物材料(细胞和 ECM)转化为产物(组织),这是生物过程的一个典型特征。通过精确地组织底物材料并时空控制产物的活性,微流控系统不仅可以“合成”活组织,还可以在体外重现免疫反应、血管生成、伤口愈合和肿瘤转移等生理或病理生理过程,从而深入了解这些在体内发生的过程的机制。在本账户中,我们借用化学“合成”的概念来描述如何从化学家的角度使用微流控技术“合成”人工组织。在微流控内置的物理化学线索和外部刺激的加速下,各种组织可以在微流控平台上“合成”。我们总结出,在微流控上有“逐步合成”和“一步合成”两种方法来以前所未有的精度、准确性和速度创建所需的组织。近年来,研究人员开发了各种微流控技术,包括创建用于介导反向和精确黏附的黏附域、用于指导细胞生长的化学梯度、用于操纵细胞迁移的几何限制和拓扑线索以及用于刺激细胞分化的力学。通过采用和协调这些芯片上的组织“合成”条件,可以在芯片上实现“逐步合成”,从而开发出多层组织,如血管。在芯片上的“一步合成”可以开发出功能性的三维组织结构,如神经网络或肾单位样结构。基于这些芯片研究,可以深入研究许多关键的生理和病理生理过程,如伤口愈合、肿瘤转移和动脉粥样硬化,并方便地评估或筛选药物或治疗方法。微流控上的“合成组织”系统将为精确创建人工组织开辟道路,不仅用于基础研究,还用于组织工程等生物医学应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验